BMS-986325 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
53シェーグレン症候群1

53. シェーグレン症候群


臨床試験数 : 305 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04684654
(ClinicalTrials.gov)
February 16, 202122/12/2020BMS-986325 in Healthy Participants and Participants With Primary Sjögren's SyndromeA Double-Blind, Placebo-Controlled, Randomized, Single and Multiple Dose Study on the Safety, Pharmacokinetics, and Exploratory Pharmacodynamics of Subcutaneous and Intravenous BMS-986325 Administration in Healthy Participants and Participants With Primary Sjögren's SyndromeHealthy Participants;Primary Sjögren's SyndromeBiological: BMS-986325;Other: Placebo for BMS-986325Bristol-Myers SquibbNULLRecruiting18 Years75 YearsAll136Phase 1United States;Germany